HOUSE RX

View full entity profile (contributions, contracts, SEC) →

Lobbying Spend

—

Filings

Firms Hired

Active Period

2024–2025

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2025	—	1	1
2024	—	4	1

Hired Firms

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
FORBES-TATE	—	5

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	4
SENATE	4

Top Issues

Most frequently reported lobbying issues

Issue Code	Description	Reports
Health Issues	Health Issues	5
Medicare/Medicaid	Medicare/Medicaid	5

Bills Explicitly Cited (20)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 5526118th Congress

Seniors’ Access to Critical Medications Act of 2024

2025 · first_quarter · Firm: FORBES-TATE

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to H.R. 5526/S. 3428 - Seniors Access to Critical Medications Act of 2023.

Client expense: — · Firm income: —

Matched citations: H.R. 5526

H.R. 5526118th Congress

Seniors’ Access to Critical Medications Act of 2024

2025 · first_quarter · Firm: FORBES-TATE

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to H.R. 5526/S. 3458 - Seniors Access to Critical Medications Act of 2023.

Client expense: — · Firm income: —

Matched citations: H.R. 5526

S. 3428118th Congress

DEFUND Act of 2023

2025 · first_quarter · Firm: FORBES-TATE

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to H.R. 5526/S. 3428 - Seniors Access to Critical Medications Act of 2023.

Client expense: — · Firm income: —

Matched citations: S. 3428

S. 3458118th Congress

Seniors’ Access to Critical Medications Act of 2023

2025 · first_quarter · Firm: FORBES-TATE

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to H.R. 5526/S. 3458 - Seniors Access to Critical Medications Act of 2023.

Client expense: — · Firm income: —

Matched citations: S. 3458

Show 16 more cited filings

H.R. 5526118th Congress

Seniors’ Access to Critical Medications Act of 2024

2024 · fourth_quarter · Firm: FORBES-TATE

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to H.R. 5526/S. 3458 - Seniors Access to Critical Medications Act of 2023.

Client expense: — · Firm income: $30,000

Matched citations: H.R. 5526

H.R. 5526118th Congress

Seniors’ Access to Critical Medications Act of 2024

2024 · fourth_quarter · Firm: FORBES-TATE

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to H.R. 5526/S. 3458 - Seniors Access to Critical Medications Act of 2023.

Client expense: — · Firm income: $30,000

Matched citations: H.R. 5526

S. 3458118th Congress

Seniors’ Access to Critical Medications Act of 2023

2024 · fourth_quarter · Firm: FORBES-TATE

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to H.R. 5526/S. 3458 - Seniors Access to Critical Medications Act of 2023.

Client expense: — · Firm income: $30,000

Matched citations: S. 3458

S. 3458118th Congress

Seniors’ Access to Critical Medications Act of 2023

2024 · fourth_quarter · Firm: FORBES-TATE

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to H.R. 5526/S. 3458 - Seniors Access to Critical Medications Act of 2023.

Client expense: — · Firm income: $30,000

Matched citations: S. 3458

H.R. 5526118th Congress

Seniors’ Access to Critical Medications Act of 2024

2024 · third_quarter · Firm: FORBES-TATE

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to H.R. 5526/S.3458 - Seniors Access to Critical Medications Act of 2023.

Client expense: — · Firm income: $30,000

Matched citations: H.R. 5526

H.R. 5526118th Congress

Seniors’ Access to Critical Medications Act of 2024

2024 · third_quarter · Firm: FORBES-TATE

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to H.R. 5526/S.3458 - Seniors Access to Critical Medications Act of 2023.

Client expense: — · Firm income: $30,000

Matched citations: H.R. 5526

S. 3458118th Congress

Seniors’ Access to Critical Medications Act of 2023

2024 · third_quarter · Firm: FORBES-TATE

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to H.R. 5526/S.3458 - Seniors Access to Critical Medications Act of 2023.

Client expense: — · Firm income: $30,000

Matched citations: S.3458

S. 3458118th Congress

Seniors’ Access to Critical Medications Act of 2023

2024 · third_quarter · Firm: FORBES-TATE

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to H.R. 5526/S.3458 - Seniors Access to Critical Medications Act of 2023.

Client expense: — · Firm income: $30,000

Matched citations: S.3458

H.R. 5526118th Congress

Seniors’ Access to Critical Medications Act of 2024

2024 · second_quarter · Firm: FORBES-TATE

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to H.R. 5526/S.3458 - SeniorsAccess to Critical Medications Act of 2023.

Client expense: — · Firm income: $10,000

Matched citations: H.R. 5526

H.R. 5526118th Congress

Seniors’ Access to Critical Medications Act of 2024

2024 · second_quarter · Firm: FORBES-TATE

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to H.R. 5526/S.3458 - Seniors Access to Critical Medications Act of 2023.

Client expense: — · Firm income: $10,000

Matched citations: H.R. 5526

S. 3458118th Congress

Seniors’ Access to Critical Medications Act of 2023

2024 · second_quarter · Firm: FORBES-TATE

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to H.R. 5526/S.3458 - Seniors Access to Critical Medications Act of 2023.

Client expense: — · Firm income: $10,000

Matched citations: S.3458

S. 3458118th Congress

Seniors’ Access to Critical Medications Act of 2023

2024 · second_quarter · Firm: FORBES-TATE

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to H.R. 5526/S.3458 - SeniorsAccess to Critical Medications Act of 2023.

Client expense: — · Firm income: $10,000

Matched citations: S.3458

H.R. 5526118th Congress

Seniors’ Access to Critical Medications Act of 2024

2024 · second_quarter · Firm: FORBES-TATE

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to HR 5526, S3458 - Seniors Access to Critical Medications Act of 2023

Client expense: — · Firm income: —

Matched citations: HR 5526

H.R. 5526118th Congress

Seniors’ Access to Critical Medications Act of 2024

2024 · second_quarter · Firm: FORBES-TATE

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to HR 5526, S3458 - Seniors Access to Critical Medications Act of 2023

Client expense: — · Firm income: —

Matched citations: HR 5526

S. 3458118th Congress

Seniors’ Access to Critical Medications Act of 2023

2024 · second_quarter · Firm: FORBES-TATE

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to HR 5526, S3458 - Seniors Access to Critical Medications Act of 2023

Client expense: — · Firm income: —

Matched citations: S3458

S. 3458118th Congress

Seniors’ Access to Critical Medications Act of 2023

2024 · second_quarter · Firm: FORBES-TATE

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to HR 5526, S3458 - Seniors Access to Critical Medications Act of 2023

Client expense: — · Firm income: —

Matched citations: S3458

Source: Senate LDA

HOUSE RX — Lobbying Disclosure | Poliscope